The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

Journal of Nutritional Biochemistry

Volumn 19, Issue 9, 2008, Pages 567-576

  Gentile, Christopher L ^a   Pagliassotti, Michael J ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

ER stress; Liver; Saturated fatty acids

Indexed keywords

ALCOHOL; CYTOKINE; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; STEARIC ACID; UNSATURATED FATTY ACID;

DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; HUMAN; HYPOTHESIS; LIVER; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW; TOXICITY;

APOPTOSIS; ENDOPLASMIC RETICULUM; FATTY ACIDS; FATTY LIVER; FATTY LIVER, ALCOHOLIC; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL; OBESITY; PROTEIN FOLDING;

EID: 48649110854     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2007.10.001     Document Type: Review

References (109)

1. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., and Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195-1200
2. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors. JAMA 289 (2003) 76-79
3. Must A., Spadano J., Coakley E.H., Field A.E., Colditz G., and Dietz W.H. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
4. Festi D., Colecchia A., Sacco T., Bondi M., Roda E., and Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 5 (2004) 27-42
5. Clark J.M., and Diehl A. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 289 (2003) 3000-3004
6. Akbar D.H., and Kawther A.H. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know. Med Sci Monit 12 (2006) RA23-RA26
7. Adams L.A., Angulo P., and Lindor K.D. Nonalcoholic fatty liver disease. CMAJ 172 (2005) 899-905
8. Ioannou G.N., Boyko E.J., and Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 101 (2006) 76-82
9. Szczepaniak L.S., Nurenberg P., Leonard D., Browning J.D., Reingold J.S., Grundy S., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288 (2005) E462-E468
10. Mofrad P.S., and Sanyal A.J. Nonalcoholic fatty liver disease. Med Gen Med 5 (2003) 14
11. Wieckowska A., McCullough A.J., and Feldstein A.E. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46 (2007) 582-589
12. Papandreou D., Rousso I., and Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin Nutr 26 (2007) 409-415
13. Abdelmalek M.F., and Diehl A. Mechanisms underlying nonalcoholic steatohepatitis. Drug Discov Today Dis Mech 3 (2006) 479-488
14. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., et al. Nonalcoholic Fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54 (2005) 3541-3546
15. Day C.P., and James O. Steatohepatitis: a tale of two "hits"?. Gastroenterology 114 (1998) 842-845
16. Yang S.Q., Lin H.Z., Mandal A.K., Huang J., and Diehl A.M. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34 (2001) 694-706
17. Ito K., Kiyosawa N., Kumagai K., Manabe S., Matsunuma N., and Yamoto T. Molecular mechanism investigation of cycloheximide-induced hepatocyte apoptosis in rat livers by morphological and microarray analysis. Toxicology 219 (2006) 175-186
18. Faggioni R., Fantuzzi G., Gabay C., Moser A., Dinarello C.A., Feingold K.R., et al. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 276 (1999) R136-R142
19. Wanless I.R., and Lentz J.S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (1990) 1106-1110
20. Lieber C.S. CYP2E1: from ASH to NASH. Hepatol Res 28 (2004) 1-11
21. Clark J., and Diehl A. Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2 (2002) 210-215
22. Harrison S.A., Kadakia S., Lang K.A., and Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 97 (2002) 2714-2724
23. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94 (1997) 2557-2562
24. Feldstein A.E., Canbay A., Angulo P., Taniai M., Burgart L.J., Lindor K.D., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443
25. Wieckowska A., Zein N.N., Yerian L.M., Lopez A.R., McCullough A.J., and Feldstein A.E. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in Nonalcoholic fatty liver disease. Hepatology 44 (2006) 27-33
26. Shimabukuro M., Zhou Y.T., Levi M., and Unger R.H. Fatty acid-induced B cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95 (1998) 2498-2502
27. Unger R.H., and Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 1585 (2002) 202-212
28. Hardy S., Langelier Y., and Prentki M. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res 60 (2000) 6353-6358
29. Listenberger L.L., Ory D.S., and Schaffer J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276 (2001) 14890-14895
30. de Vries J.E., Vork M.M., Roemen T.H., de Jong Y.F., Cleutjens J.P., van der Vusse G.J., et al. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 38 (1997) 1384-1394
31. Maedler K., Spinas G.A., Dyntar D., Moritz W., Kaiser N., and Donath M.Y. Distinct effects of saturated and unsaturated fatty acids on B-cell turnover and function. Diabetes 50 (2001) 69-76
32. Paumen M.B., Ishida Y., Muramatsu M., Yamamoto M., and Honjo T. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 272 (1997) 3324-3329
33. Wang D., Wei Y., and Pagliassotti M.J. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147 (2006) 943-951
34. Wei Y., Wang D., Topczewski F., and Pagliassotti M.J. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291 (2006) E275-E281
35. Wei Y., Wang D., and Pagliassotti M.J. Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells. Mol Cell Biochem (2007)
36. Pagliassotti M.J., Wei Y., and Wang D. Insulin protects liver cells from saturated fatty acid-induced apoptosis via inhibition of c-Jun NH2 terminal kinase activity. Endocrinology 148 (2007) 3338-3345
37. Malhi H., Bronk S.F., Werneburg N.W., and Gores G.J. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281 (2006) 12093-12101
38. Listenberger L.J., Han X., Lewis S.E., Cases S., Farese R.V., Ory D.S., et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100 (2003) 3077-3082
39. Kharroubi I., Ladriere L., Cardozo A.K., Dogusan Z., Cnop M., and Eizirik D.L. Free fatty acids and cytokines induce pancreatic B-cell apoptosis by different mechanisms: role of nuclear factor-KB and endoplasmic reticulum stress. Endocrinology 145 (2004) 5087-5096
40. Pagliassotti M.J., Prach P.A., Koppenhafer T.A., and Pan D.A. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol 271 (1996) R1319-R1326
41. Commerford S.R., Ferniza J.B., Bizeau M.E., Thresher J.S., Willis W.T., and Pagliassotti M.J. Diets enriched in sucrose or fat increase gluconeogenesis and G-6-Pase but not basal glucose production in rats. Am J Physiol Endocrinol Metab 283 (2002) E545-E555
42. Gulbins E., and Li P.L. Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol 290 (2005) R11-R26
43. Kurinna S.M., Tsao C.C., Nica A.F., Jiffar T., and Ruvolo P.P. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase. Cancer Res 64 (2004) 7852-7856
44. Willaime-Morawek S., Brami-Cherrier K., Mariani J., Caboche J., and Brugg B. C-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 119 (2003) 387-397
45. Ruvolo P.P. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47 (2003) 383-392
46. Cacicedo J.M., Benjachareowong S., Chou E., Ruderman N.B., and Ido Y. Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 54 (2005) 1838-1845
47. Buttke T.M., and Sandstrom P.A. Redox regulation of programmed cell death in lymphocytes. Free Radic Res 22 (1995) 389-397
48. Jacobson M.D. Reactive oxygen species and programmed cell death. Trends Biochem Sci 21 (1996) 83-86
49. Mignotte B., and Vayssiere J.L. Mitochondria and apoptosis. Eur J Biochem 252 (1998) 1-15
50. Aronis A., Madar Z., and Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Rad Biol Med 38 (2005) 1221-1230
51. Boldt S., and Kolch W. Targeting MAPK signaling: Prometheus' fire or Pandora's box. Curr Pharm Des 10 (2004) 1885-1905
52. Bogoyevitch M.A., Boehm I., Oakley A., Ketterman A.J., and Barr R.K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta 1697 (2004) 89-101
53. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
54. Czaja M.J. The future of GI and liver research: editorial perspectives: III. JNK/AP-1 regulation of hepatocyte death. Am J Physiol Gastrointest Liver Physiol 284 (2002) G875-G879
55. Pahl H.L. Signal transduction from the endoplasmic reticulum to the cell nucleus. Physiol Rev 79 (1999) 683-701
56. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13 (1999) 1211-1233
57. Kaufman R.J. Orchestrating the unfolded protein response in health and disease. J Clin Invest 110 (2002) 1389-1398
58. Schroder M., and Kaufman R.J. ER stress and the unfolded protein response. Mutat Res 569 (2005) 29-63
59. Ron D., and Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8 (2007) 519-529
60. Zhang K., and Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 279 (2004) 25935-25938
61. Shen J., and Prywes R. ER stress signaling by regulated proteolysis of ATF6. Methods 35 (2005) 382-389
62. Lee K., Tirasophon W., Shen X., Michalak M., Prywes R., Okada T., et al. IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev 16 (2002) 452-466
63. Thuerauf D.J., Morrison L., and Glembotski C.C. Opposing roles for ATF6a and ATF6b in endoplasmic reticulum stress response gene induction. J Biol Chem 279 (2004) 21078-21084
64. Wek R.C., Jiang H.Y., and Anthony T.G. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 34 (2006) 7-11
65. Hong M., Luo S., Baumeister P., Huang J.-M., Gogia R.K., Li M., et al. Underglycosylation of ATF6 as a novel sensing mechanism for activation of the unfolded protein response. J Biol Chem 279 (2004) 11354-11363
66. Back S.H., Schroder M., Lee K., Zhang K., and Kaufman R.J. ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods 35 (2005) 395-416
67. Rutkowski D.T., and Kaufman R.J. A trip to the ER: coping with stress. Trends Cell Biol 14 (2004) 20-28
68. Harding H.P., Zeng H., Zhang Y., Jungries R., Chung P., Plesken H., et al. Diabetes mellitus and exocrine pancreatic dysfunction in Perk)/) mice reveals a role for translational control in secretory cell survival. Mol Cell 7 (2001) 1153-1163
69. Scheuner D., Song B., McEwen E., Liu C., Laybutt R., Gillespie P., et al. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell 7 (2001) 1165-1176
70. Kim S.H., Hwang C.I., Park W.Y., Lee J.H., and Song Y.S. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells. Carcinogenesis 27 (2006) 1961-1969
71. Oyadomari S., and Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11 (2004) 381-389
72. Oyadomari S., Koizumi A., Takeda K., Gotoh T., Akira S., Araki E., et al. Targeted disruption of the Chop gene delays endoplasmic reticulum-stress mediated diabetes. J Clin Invest 109 (2002) 525-532
73. Shi Y., Taylor S.I., Tan S.-L., and Sonenberg N. When translation meets metabolism: multiple links to diabetes. Endocr Rev 24 (2003) 91-101
74. Zhao L., and Ackerman S.L. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol (2006)
75. Wang D., Wei Y., Schmoll D., Maclean K.N., and Pagliassotti M.J. Endoplasmic reticulum stress increases glucose-6-phosphatase and glucose cycling in liver cells. Endocrinology 147 (2006) 350-358
76. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action and type 2 diabetes. Science 306 (2004) 457-461
77. Spector A.A., and Yorek M.A. Membrane lipid composition and cellular function. J Lipid Res. 26 (1985) 1015-1035
78. Feng B., Yao P.M., Li Y., Devlin C.M., Zhang D., Harding H.P., et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat Cell Biol 5 (2003) 781-792
79. Turner M.D. Fatty acyl CoA-mediated inhibition of endoplasmic reticulum assembly. Biochim Biophys Acta 1693 (2004) 1-4
80. Busch A.K., Gurisik E., Cordery D.V., Sudlow M., Denyer G.S., Laybutt D.R., et al. Increased fatty acid desaturation and enhanced expression of stearoyl coenzyme A desaturase protects pancreatic B-cells from lipoapoptosis. Diabetes 54 (2005) 2917-2924
81. Moffitt J.H., Fielding B.A., Evershed R., Berstan R., Currie J.M., and Clark A. Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro. Diabetologia 48 (2005) 1819-1829
82. Borradaile N.M., Han X., Harp J.D., Gale S.E., Ory D.S., and Schaffer J.E. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res 47 (2006) 2726-2737
83. Mills S.J., and Harrison S.A. Comparison of the natural history of alcoholic and nonalcoholic Fatty liver disease. Curr Gastroenterol Rep 7 (2005) 32-36
84. Naveau S., Giraud V., Borotto E., Aubert A., Capron F., and Chaput J.C. Excess weight risk factor for alcoholic liver disease. Hepatology 25 (1997) 108-111
85. Raynard B., Balian A., Fallik D., Capron F., Bedossa P., Chaput J.C., et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35 (2002) 635-638
86. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343 (2000) 1467-1476
87. Stewart S., Jones D., and Day C.P. Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol Med 7 (2001) 408-413
88. Ji C., and Kaplowitz N. Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 124 (2003) 1488-1499
89. Ji C., Deng Q., and Kaplowitz N. Role of TNF-alpha in ethanol-induced hyperhomocysteinemia and murine alcoholic liver injury. Hepatology 40 (2004) 442-451
90. Ji C., Mehrian-Shai R., Chan C., Hsu Y.H., and Kaplowitz N. Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 29 (2005) 1496-1503
91. Nanji A.A., Mendenhall C.L., and French S.W. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 13 (1989) 15-19
92. Nanji A.A., Jokelainen K., Tipoe G.L., Rahemtulla A., and Dannenberg A.J. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther 299 (2001) 638-644
93. Nanji A.A., Zakim D., Rahemtulla A., Daly T., Miao L., Zhao S., et al. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 26 (1997) 1538-1545
94. Ronis M.J., Korourian S., Zipperman M., Hakkak R., and Badger T.M. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. J Nutr 134 (2004) 904-912
95. Morimoto M., Hagbjork A.L., Nanji A.A., Ingelman-Sundberg M., Lindros K.O., Fu P.C., et al. Role of cytochrome P4502E1 in alcoholic liver disease pathogenesis. Alcohol 10 (1993) 459-464
96. Nanji A.A., Yang E.K., Fogt F., Sadrzadeh S.M.H., and Dannenberg A.J. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 277 (1996) 1694-1700
97. You M., Considine R.V., Leone T.C., Kelly D.P., and Crabb D.W. Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology 42 (2005) 568-577
98. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14 (2003) 281-287
99. Rachek L.I., Musiyenko S.I., Ledoux S.P., and Wilson G.L. Palmitate induced mtDNA damage and apoptosis in L6 rat skeletal muscle cells. Endocrinology (2006)
100. Zou Y., Li J., Lu C., Wang J., Ge J., Huang Y., et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci (2006)
101. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., and Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115 (2005) 1343-1351
102. Bazzano L.A., Serdula M., and Liu S. Prevention of type 2 diabetes by diet and lifestyle modification. J Am Coll Nutr 24 (2005) 310-319
103. Bizeau M.E., and Pagliassotti M.J. Hepatic adaptations to sucrose and fructose. Metabolism 54 (2005) 1189-1201
104. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63 (2005) 133-157
105. Bolton-Smith C., and Woodward M. Dietary composition and fat to sugar ratios in relation to obesity. Int J Obes Relat Metab Disord 18 (1994) 820-828
106. Musso G., Gambino R., De Michieli F., Cassader M., Rizzetto M., Durazzo M., et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37 (2003) 909-916
107. Kang H., Greenson J.K., Omo J.T., Chao C., Peterman D., Anderson L., et al. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD. Am J Gastroenterol 101 (2006) 2247-2253
108. Huang M.A., Greenson J.K., Chao C., Anderson L., Peterman D., Jacobson J., et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 100 (2005) 1072-1081
109. Vessby B., Aro A., Skarfors E., Berglund L., Salminen I., and Lithell H. The risk to develop NIDDM is related to the fatty acid composition of the serum cholesterol esters. Diabetes 43 (1994) 1353-1357